Iran is considering the purchase of two million doses of the Pfizer-BioNTech vaccine, as the country continues to battle the Middle East’s deadliest outbreak.
« A contract is being drawn up with the Iranian foreign exchange office for the import within one to two months of two million doses of the Pfizer vaccine produced in Belgium, » said senior health official Mohammad-Reza Shanehsaz.
« At present, six vaccines, Sputnik, AstraZeneca, Sinopharm, Bharat, Pfizer produced in Belgium and Johnson & Johnson produced in Germany, have been given the green light, » he said, quoted by Fars news agency.
The authorities have also approved for emergency use two domestically produced vaccines, including COViran Barekat, which is in short supply.
The country has so far received more than 60 million vaccine doses, including from China, according to media reports.
Toute l’actualité en temps réel, est sur L’Entrepreneur
